Healthcare Services

Large And Small-Scale Bioprocessing Market Future Outlook Showing Expansion Toward $119.99 Billion by 2030

April 2, 2026April 15, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Large And Small-Scale Bioprocessing Market Over The 2026–2030 Period?

The large and small-scale bioprocessing market size has experienced significant expansion in recent years. It is projected to grow from $67.66 billion in 2025 to $76.73 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.4%. The historical growth of this market can be attributed to the expansion of biopharmaceutical manufacturing, increased investment in biotechnology R&D, the broadening of fermentation-based production, an escalating use of cell culture technologies, and the advancement in large-scale stainless steel bioreactors.

The large and small-scale bioprocessing market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $119.99 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.8%. This projected growth is primarily driven by factors such as the increasing demand for biologics and biosimilars, a greater uptake of single-use technologies, the expansion of personalized and precision medicine, the broadening of CDMO services, and a heightened emphasis on sustainable bioprocessing techniques. Key developments expected during this period involve the increasing integration of single-use and modular bioprocessing systems, an escalating need for adaptable small-scale bioprocessing solutions in research and development, the broadening of contract biomanufacturing and outsourcing frameworks, a stronger emphasis on achieving process scalability from laboratory to commercial production, and the enhanced merging of upstream and downstream bioprocess workflows.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15845&type=smp

Which Economic Or Industry Drivers Are Impacting The Large And Small-Scale Bioprocessing Market?

The increasing requirement for biologics is anticipated to drive expansion in the large and small-scale bioprocessing market moving ahead. Biologics are defined as medical products originating from living organisms or their constituents, encompassing items like vaccines, blood products, gene therapies, tissues, and recombinant therapeutic proteins. This rising demand for biologics stems from progress in biotechnology, enhanced comprehension of disease processes, and the desire for specialized and individualized treatments. Both large-scale and small-scale bioprocessing play crucial roles in the effective development and commercialization of biologics. Small-scale bioprocessing is vital for initial development phases, optimization efforts, and feasibility assessments. Conversely, large-scale bioprocessing guarantees the efficient, consistent production of biologics, adhering to regulatory standards for their commercial release. As an illustration, data from February 2024, provided by the National Library of Medicine, a US-based medical library, indicated that in 2023, the Food and Drug Administration (FDA) approved 55 new drugs, which comprised 29 new chemical entities (NCEs) and 25 new biological entities (NBEs). This represented a 50% increase over the 37 approvals recorded in 2022. Consequently, the increasing requirement for biologics fuels the expansion of the large and small-scale bioprocessing market.

How Is The Large And Small-Scale Bioprocessing Market Segmented Across Key Categories?

The large and small-scale bioprocessing market covered in this report is segmented –

1) By Product: Bioreactors Or Fermenters, Cell Culture Products, Filtration Assemblies, Bioreactors Accessories, Bags And Containers, Other Products

2) By Mode: In-house, Outsourced

3) By Workflow: Downstream Processing, Fermentation, Upstream Processing

4) By Scale: Industrial Scale, Small Scale

5) By Application: Biopharmaceuticals, Specialty Industrial Chemicals, Environmental Aids

Subsegments:

1) Bioreactors Or Fermenters: Single-Use Bioreactors, Stainless Steel Bioreactors, Glass Bioreactors

2) Cell Culture Products: Cell Culture Media, Sera And Supplements, Reagents

3) Filtration Assemblies: Membrane Filters, Depth Filters, Tangential Flow Filtration Systems

4) Bioreactor Accessories: Spargers, Impellers, Sensors And Probes

5) Bags And Containers: Single-Use Bags, Storage Containers, Transfer Bags

6) Other Products: Mixers, Tubing And Connectors, Sampling Systems

What Key Trends Are Influencing The Development Of The Large And Small-Scale Bioprocessing Market?

Major companies within the large and small-scale bioprocessing market are dedicated to developing innovative solutions, such as fixed-bed, low-footprint bioreactor controllers. This focus is driven by the booming fields of gene therapies, vaccines, and biologics, which demand high-productivity, cost-efficient, and scalable viral vector and advanced therapy manufacturing. A fixed-bed, low-footprint bioreactor controller serves as specialized hardware designed to manage large-area cell culture within fixed-bed reactors, distinguishing itself from conventional large-scale stirred-tank bioreactors—which require substantial physical space, significant capital investment, and complex infrastructure—by offering a compact form factor, an intuitive user interface, and optimized fluid handling. For instance, in May 2025, Univercells Technologies SA, a bioprocessing company from Belgium, unveiled the scale-X Nitro Controller. This controller is specifically engineered to operate their 200 m² and 600 m² scale-X Nitro fixed-bed bioreactors. It presents as a compact, wheeled unit with a 1.6 m² footprint, allowing it to easily pass through standard cleanroom doors. Furthermore, it supports both adherent and suspension cultures and provides highly intuitive control. The system facilitates rapid scale-up from research and development to commercial manufacturing in approximately ~8 months, while simultaneously reducing the cost-of-goods by 36–82% compared to traditional adherent processes. Ultimately, by combining high productivity with a simplified, space-saving design, the scale-X Nitro Controller empowers biomanufacturers, particularly CDMOs and vaccine developers, to accelerate their development timelines and lower the economic barrier for large-scale viral production.

Who Are The Dominant Players Shaping The Large And Small-Scale Bioprocessing Market Landscape?

Major companies operating in the large and small-scale bioprocessing market are F. Hoffmann-La Roche AG, Novartis AG, Sanofi S.A., Pfizer Inc., Merck & Co. Inc., Bristol Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Ltd., Eli Lilly and Company, AbbVie Inc., Amgen Inc., Biogen Inc., Regeneron Pharmaceuticals Inc., Genentech Inc., Gilead Sciences Inc., Novo Nordisk A/S, CSL Limited, UCB S.A., Samsung Biologics, WuXi Biologics, Boehringer Ingelheim

Read the full large and small-scale bioprocessing market report here:

https://www.thebusinessresearchcompany.com/report/large-and-small-scale-bioprocessing-global-market-report

What Are The Top-Performing Regions Within The Large And Small-Scale Bioprocessing Market?

North America was the largest region in the large and small-scale bioprocessing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the large and small-scale bioprocessing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Large And Small-Scale Bioprocessing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15845&type=smp

Browse Through More Reports Similar to the Global Large And Small-Scale Bioprocessing Market 2026, By The Business Research Company

Single Use Bioprocessing Global Market Report

https://www.thebusinessresearchcompany.com/report/single-use-bioprocessing-global-market-report

Bioprocessing Technology Global Market Report

https://www.thebusinessresearchcompany.com/report/bioprocessing-technology-global-market-report

Bioprocess Technology Global Market Report

https://www.thebusinessresearchcompany.com/report/bioprocess-technology-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795